Tue.Jan 23, 2024

article thumbnail

World’s largest catalogue of ocean DNA could boost drug discovery

Drug Discovery World

The world’s most comprehensive database for understanding microbial distribution and function in the ocean has been released, opening up new opportunities for drug discovery. Scientists at the King Abdullah University of Science and Technology (KAUST) in Thuwal, Saudi Arabia used the KAUST Metagenomic Analysis Platform (KMAP) to analyse massive amounts of sequencing data to release Global Ocean Gene Catalog 1.0.

DNA 259
article thumbnail

Anti?tumor efficacy of emodin on colorectal cancer cells via targeting lncRNA HLA complex P5

Chemical Biology and Drug Design

Emodin is a naturally occurring anthraquinone derivative with a variety of pharmacologic effects, but its role in colorectal cancer (CRC) has hardly been investigated. The current findings showed that emodin repressed the viability, migration, and invasion of CRC cells and suppressed EMT via inhibition of HCP5 expression. Abstract Emodin is a naturally occurring anthraquinone derivative with a variety of pharmacologic effects, but its role and regulatory mechanism in colorectal cancer (CRC) rema

RNA 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Comment: Reflections from Genesis 2023 

Drug Discovery World

The annual Genesis conference took place at the end of 2023 in London, bringing together key opinion leaders, investors and innovators from across the life sciences sector to exchange insights, debate trends and generate deals. DDW’s Megan Thomas attended and reflects on highlights of the programme. Stacking the deck of ‘luck’ The first panel of the day, which followed One Nucleus’ Jon Green’s welcome and Clarivate’s Mike Ward on his annual Winners & Losers keynote presentation, was on t

Science 148
article thumbnail

Discovery of novel chromone and acrylate?based pancreatic lipase inhibitors: Molecular modelling, synthesis, and in vitro evaluation for the treatment of obesity

Chemical Biology and Drug Design

A novel series of chromone and acrylate-based PL inhibitors were designed with the analogue 9a , being potent of the series, exhibiting IC 50 of 3.32 ± 0.224 μM. Also, the fluorescence quenching and enzyme kinetics study proved the competitive nature of inhibition. Abstract By the optimization of previously established pancreatic lipase (PL) inhibitory lead, we have developed novel chromone-containing analogues with embedded acrylate fragment as potential PL inhibitors.

Treatment 100
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

SLAS2024 update: New tech accelerates drug development

Drug Discovery World

The SLAS Ignite Theater ‘ Innovation & technology: from lab to patient ’, co-sponsored by Integra Biosciences and Hamamatsu Corporation, will take place at SLAS2024 in Boston on 5 and 6 February 2024. Developed by DDW in partnership with SLAS, the programme will feature leading research from experts in academia, government and industry. Professor Anubhav Tripathi One of the featured speakers, Anubhav Tripathi, Professor of Medical Science and Engineering at Brown University, will address the

article thumbnail

Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product

Chemical Biology and Drug Design

Human UCP classification and its tissue distribution. Abstract Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with lipid deposition in liver cells and/or subsequent inflammation, excluding other known causes. NAFLD is a subset of metabolic syndrome that ranges from simple steatohepatitis (NASH), fibrosis to cirrhosis and hepatocellular carcinoma (HCC).

More Trending

article thumbnail

Investigation on the antipyretic mechanism of Chaiqin Qingning capsule for the treatment of fever based on network pharmacology, molecular docking, and in vitro experimental validation

Chemical Biology and Drug Design

We used an integrative methods to investigate and elucidate the molecular mechanism of Chaiqin Qingning capsule (CQQNC) in the treatment of fever. We found that CQQNC possibly inhibited the synthesis and secretion of PGE2 to exert its antipyretic effects and the in vitro study has confirmed our findings. Abstract Chaiqin Qingning Capsule (CQQNC), a traditional Chinese patent medicine, can effectively shorten the duration of fever and significantly improve fever symptoms.

Treatment 100
article thumbnail

Breast cancer most researched disease area for third year running

Drug Discovery World

Breast cancer was the most studied disease in 2023 for the third consecutive year, followed by solid tumours, stroke, Covid-19 and prostate cancer. The analysis of 65,749 recruiting clinical trials was conducted by data analytics company Phesi, as part of an annual global analysis of clinical trials using data from its Trial Accelerator platform. Phesi’s analysis also revealed that the US is home to 33% of the 115,000 recruiting investigator sites from interventional trials around the world – wi

Disease 130
article thumbnail

Matrine inhibits cell proliferation, invasion, and stem cell formation in hepatocellular carcinoma by regulating the ELAVL1/RBM3?mediated Wnt/??catenin signaling pathway

Chemical Biology and Drug Design

Matrine inhibits the growth and metastasis of hepatocellular carcinoma by regulating the ELAVL1/RBM3-mediated Wnt/β-catenin signaling pathway. Abstract Matrine has been reported to exert anti-tumor effects in various cancers, including hepatocellular carcinoma (HCC). Nevertheless, the anti-tumor molecular mechanism of Martine in HCC is still not fully revealed.

article thumbnail

Immuno-oncology innovations redefining cancer treatment in 2024

Drug Target Review

What innovative approaches and technologies are anticipated to reshape immuno-oncology treatments in 2024? Immuno-oncology, notably through checkpoint inhibitors, has significantly reshaped cancer treatment over the past decade. The current shift focuses on enhancing their efficacy by addressing the crucial need for robust T cell responses, an apparent bottleneck for broader impact.

Treatment 122
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Betulinic acid reduces inflammation in rats with sepsis?induced myocardial dysfunction by inhibiting TLR4/MyD88/NF??B signaling pathway

Chemical Biology and Drug Design

Betulinic acid (BA) improved cardiac function, reduced myocardial injury, and attenuated inflammation in the cecal ligation and puncture (CLP) rats, indicating BA as a potential drug for sepsis-induced myocardial dysfunction. The mechanism may related to inhibit TLR4/MyD88/NF-κB signaling and promote M2 macrophage polarization in myocardial tissues.

article thumbnail

Allergy Alert: What Could New Guidelines on Anaphylaxis Mean for You?

Drugs.com

TUESDAY, Jan. 23, 2024 -- If you or someone close to you suffers from severe allergic reactions, you have probably heard there are new recommendations out that offer guidance on the diagnosis, management and treatment of anaphylaxis.The latest.

Treatment 116
article thumbnail

In vivo anticancer study of sodium 2?[(4?oxidobenzylidene)amino]?6H?1,3,4?thiadiazine?5?olate against Ehrlich ascites carcinoma via targeting PI3K/mTOR pathway

Chemical Biology and Drug Design

Sodium 2-[(4-oxidobenzylidene)amino]-6H-1,3,4-thiadiazine-5-olate exhibited significant in vivo anticancer agent against Ehrlich ascites carcinoma via dual inhibition of PI3K and mTOR. It displayed an antioxidant effect by decreasing MDA levels and increasing TAC levels. Also, it induced apoptosis by upregulation of caspase-3 and p53. Molecular docking studies had also been performed.

article thumbnail

FDA orders new cancer warnings for CAR-T therapies

BioPharma Drive: Drug Pricing

A black box warning for secondary T cell malignancies should be added to the labeling of all six approved CAR-T therapies, the agency said.

Therapies 124
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Turns Out Dogs Have Fave Things to Watch on TV

Drugs.com

TUESDAY, Jan. 23, 2024 -- Ever wonder what your dog most likes to watch on TV?Think nature documentaries, Lassie or good old Scooby-Doo, a new study suggests.Dogs are most engaged when watching videos that feature other animals, according to a new.

105
105
article thumbnail

Decoding DI in Optimizely CMS 12

Perficient: Drug Development

DI or Dependency Injection is a complex topic, not just in Optimizely CMS, but in general in.net core implementations. Some aspects we get, like the different ways dependencies can be injected and which is better over others, while some leave us scratching our heads. Often times we end up doing a lot of troubleshooting, digging into internal code and finding the right alternatives to DI, to get things to work.

article thumbnail

Flu, COVID Are Spreading: Protect Your Heart

Drugs.com

TUESDAY, Jan. 23, 2024 -- Flu and COVID are sweeping across the country, posing a particular hazard to people at risk for heart disease.These respiratory infections can trigger heart complications from fever, dehydration and inflammation, experts.

105
105
article thumbnail

Uncovering the secrets behind the silent flight of owls

Science Daily: Pharmacology News

Owls produce negligible noise while flying. While many studies have linked the micro-fringes in owl wings to their silent flight, the exact mechanisms have been unclear. Now, a team of researchers has uncovered the effects of these micro-fringes on the sound and aerodynamic performance of owl wings through computational fluid dynamic simulations. Their findings can inspire biomimetic designs for the development of low-noise fluid machinery.

article thumbnail

New Advances in Deep Brain Stimulation Treatment for Parkinson's

Drugs.com

TUESDAY, Jan. 23, 2024 -- Two new strategies using deep brain stimulation can improve symptoms of Parkinson’s disease, Duke University researchers have found.Doctors can efficiently improve symptoms of Parkinson’s by simultaneously targeting to.

Treatment 105
article thumbnail

2023 and 2024: Reflections and Looking Ahead

addgene Blog

With renewed energy and optimism that comes at the start of every new year, it is a wonderful opportunity to once again reflect on our achievements in the last year and share the exciting things to come in the new year. I am proud of what we accomplished in 2023 and thrilled to be sharing our plans for 2024.

83
article thumbnail

Detergent Pod Poisoning Threat to Kids Hasn't Gone Away

Drugs.com

TUESDAY, Jan. 23, 2024 -- The health dangers posed by colorful detergent pods continues to plague young children, a new study warns.U.S. poison control centers still receive one call every 44 minutes about a young child who’s been harmed through.

105
105
article thumbnail

Water, water everywhere and now we may have drops to drink

Science Daily: Pharmacology News

Researchers have achieved a major breakthrough in Redox Flow Desalination (RFD), an emerging electrochemical technique that can turn seawater into potable drinking water and also store affordable renewable energy.

article thumbnail

Black People Far More Likely to Get Glaucoma, and Genes May Explain Why

Drugs.com

TUESDAY, Jan. 23, 2024 -- Black people are five times as likely as others to develop glaucoma and up to 15 times more likely to be blinded by the degenerative eye disease.Now, a new study reports that genetics appears to be at least one factor.

103
103
article thumbnail

Research from the Korea University College of Medicine explores the combined health impact of diabetes and sarcopenia in the elderly

SCIENMAG: Medicine & Health

Diabetes mellitus and sarcopenia pose a substantial challenge to public health, especially among the elderly. These conditions share common pathophysiological mechanism and are linked bidirectionally, with each contributing to an increased risk of the other.

article thumbnail

New video camera system captures the colored world that animals see, in motion

Science Daily: Pharmacology News

A new camera system allows ecologists and filmmakers to produce videos that accurately replicate the colors that different animals see in natural settings.

80
article thumbnail

Walking fitness can predict fracture risk in older adults

SCIENMAG: Medicine & Health

The ability to walk one kilometre comfortably can help predict fracture risk, according to researchers at the Garvan Institute of Medical Research.

article thumbnail

Sanofi to buy Inhibrx in deal worth up to $2.2B

BioPharma Drive: Drug Pricing

The acquisition will give Sanofi an experimental drug for alpha-1 antitrypsin deficiency, while the rest of Inhibrx's assets will be spun out into a new company.

Drugs 70
article thumbnail

Terasaki Institute for Biomedical Innovation awarded NIH grant to develop allograft-rejection-on-a-chip model

SCIENMAG: Medicine & Health

(LOS ANGELES) – January 23, 2024 – Vadim Jucaud, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been awarded a grant from the National Institutes of Health to develop a functional organ-on-a-chip to model allogeneic transplant rejection.

78
article thumbnail

Cover Image

Chemical Biology and Drug Design

Cover Image © molekuul_be/Shutterstock.

100
100
article thumbnail

Study: AI surveillance tool successfully helps to predict sepsis, saves lives

SCIENMAG: Medicine & Health

Each year, at least 1.7 million adults in the United States develop sepsis, and approximately 350,000 will die from the serious blood infection that can trigger a life-threatening chain reaction throughout the entire body. Credit: UC San Diego Health Each year, at least 1.

77
article thumbnail

Medicare Part D in 2024: Smaller Pharmacies Abandon Preferred Pharmacy Networks

Drug Channels

In a previous article , I highlighted the largest pharmacy chains that will participate in the 2024 Medicare Part D prescription drug plans (PDP). Today, I update DCI's exclusive analysis of how smaller pharmacies will participate as preferred cost sharing pharmacies via the pharmacy services administrative organizations (PSAOs) that represent them in negotiations with plans.

article thumbnail

A new 3D bioprinted model offers a novel tool to study common liver disease, and perhaps find an effective treatment

SCIENMAG: Medicine & Health

Metabolic dysfunction- associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly 24% of adults having nonalcoholic fatty liver disease (NAFLD).

Disease 77
article thumbnail

Pharmas back Accent’s plan to make RNA-targeting cancer drugs

BioPharma Drive: Drug Pricing

J&J and Bristol Myers joined the latest funding round for the startup, which was led by the newly launched Mirae Asset Capital Life Science.

RNA 70
article thumbnail

Few patients successfully treat their type 2 diabetes through weight loss

SCIENMAG: Medicine & Health

A new study finds that very few patients diagnosed with type 2 diabetes are able to achieve normal blood glucose levels through weight loss alone. A team led by Andrea Luk of the Chinese University of Hong Kong, report these findings January 23rd in the open access journal PLOS Medicine.

75